Evidence map›Paper›PMID 21402778›Full record

ArticleMolecular and cellular biology2011

Activation of protein kinase Tel1 through recognition of protein-bound DNA ends.

Kenzo Fukunaga, Youngho Kwon, Patrick Sung, Katsunori Sugimoto

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. γH2A/γH2AX Mediates DNA Damage-Specific Control of Checkpoint Signaling inInternational journal of molecular sciences · 2024
    Article
  5. Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM).Critical reviews in biochemistry and molecular biology · 2021
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 3 countries.

Kenzo FukunagaDepartment of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ 07101, USA.
Youngho Kwon
Patrick Sung
Katsunori Sugimoto
Rutgers, The State University of New Jersey · US

Funding

YEAST DNA REPAIR GENES AND PROTEINS OF THE RAD52 GROUPR01ES007061 · NIEHS · YALE UNIVERSITY · PI Patrick Sung · 1995 to 2026
$9.4M
Signaling network of Mec1 in DNA damage responseR01GM073876 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SUGIMOTO, KATSUNORI · 2005 to 2013
$2.7M
Surveillance and maintenance of DNA endsR01CA148939 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SUGIMOTO, KATSUNORI · 2011 to 2015
$1.4M
NCI NIH HHS R01 CA148939NIEHS NIH HHS ES007061NIEHS NIH HHS R01 ES007061NIGMS NIH HHS GM073876NIGMS NIH HHS R01 GM073876
6 · The paper itself

Abstract

Double-strand breaks (DSBs) in chromosomal DNA elicit a rapid signaling response through the ATM protein kinase. ATM corresponds to Tel1 in budding yeast. Here we show that the catalytic activity of Tel1 is altered by protein binding at DNA ends via the Mre11-Rad50-Xrs2 (MRX) complex. Like ATM, Tel1 is activated through interaction with the MRX complex and DNA ends. In vivo, Tel1 activation is enhanced in sae2Δ or mre11-3 mutants after camptothecin treatment; both of these mutants are defective in the removal of topoisomerase I from DNA. In contrast, an sae2Δ mutation does not stimulate Tel1 activation after expression of the EcoRI endonuclease, which generates "clean" DNA ends. In an in vitro system, tethering of Fab fragments to DNA ends inhibits MRX-mediated DNA end processing but enhances Tel1 activation. The mre11-3 mutation abolishes DNA end-processing activity but does not affect the ability to enhance Tel1 activation. These results support a model in which MRX controls Tel1 activation by recognizing protein-bound DNA ends.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCamptothecinCell Cycle ProteinsDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA, FungalDNA Topoisomerases, Type IEndodeoxyribonucleasesEnzyme ActivationExodeoxyribonucleasesHistonesImmunoglobulin Fab FragmentsIntracellular Signaling Peptides and ProteinsMutationPhleomycinsProtein Serine-Threonine KinasesAtaxia Telangiectasia Mutated ProteinsCamptothecinCell Cycle ProteinsDNA-Binding ProteinsDNA, FungalDNA Topoisomerases, Type IEndodeoxyribonucleasesExodeoxyribonucleasesHistonesImmunoglobulin Fab FragmentsIntracellular Signaling Peptides and ProteinsMRE11 protein, S cerevisiaePhleomycinsProtein Serine-Threonine KinasesRAD50 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTEL1 protein, S cerevisiaeTumor Suppressor ProteinsXRS2 protein, S cerevisiae

Identifiers

PMID21402778
PMCPMC3133365
OpenAlexW2148045256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.